Clinical Trial Update: Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This document reports an update on a Phase 2 trial of Pazopanib in patients with recurrent or metastatic head and neck squamous cell carcinoma; the status is li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN